Recent insider trading activity from Kronmiller Matthew, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 3, 2025 | Damora Therapeutics, Inc. | $DMRA | Kronmiller Matthew | EVP Strategy and CBO | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 9, 2024 | Damora Therapeutics, Inc. | $DMRA | Kronmiller Matthew | EVP Strategy and CBO | A | Stock Option (right to buy) | 8600 | $0.00 | 8,600.0000 | 0 | 9999.99% | 0.00% |